Jane Street’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-113,150
| Closed | -$344K | – | 11075 |
|
|
2024
Q4 | $344K | Sell |
113,150
-455,504
| -80% | -$1.98M | ﹤0.01% | 7509 |
|
|
2024
Q3 | $2.95M | Buy |
568,654
+404,741
| +247% | +$2.01M | ﹤0.01% | 3742 |
|
|
2024
Q2 | $421K | Buy |
163,913
+24,012
| +17% | +$82K | ﹤0.01% | 7292 |
|
|
2024
Q1 | $688K | Buy |
139,901
+82,716
| +145% | +$490K | ﹤0.01% | 6110 |
|
|
2023
Q4 | $503K | Sell |
57,185
-89,797
| -61% | -$736K | ﹤0.01% | 6744 |
|
|
2023
Q3 | $1.69M | Buy |
146,982
+34,995
| +31% | +$673K | ﹤0.01% | 4324 |
|
|
2023
Q2 | $2.83M | Sell |
111,987
-162,812
| -59% | -$5.07M | ﹤0.01% | 3598 |
|
|
2023
Q1 | $8.85M | Buy |
274,799
+249,255
| +976% | +$7.77M | ﹤0.01% | 1768 |
|
|
2022
Q4 | $472K | Sell |
25,544
-221,521
| -90% | -$5.07M | ﹤0.01% | 6232 |
|
|
2022
Q3 | $6.67M | Buy |
247,065
+206,702
| +512% | +$4.19M | ﹤0.01% | 2188 |
|
|
2022
Q2 | $558K | Sell |
40,363
-59,973
| -60% | -$923K | ﹤0.01% | 6530 |
|
|
2022
Q1 | $1.96M | Buy |
100,336
+70,636
| +238% | +$1.07M | ﹤0.01% | 4807 |
|
|
2021
Q4 | $485K | Sell |
29,700
-6,261
| -17% | -$104K | ﹤0.01% | 7328 |
|
|
2021
Q3 | $1M | Buy |
+35,961
| New | +$1.03M | ﹤0.01% | 5901 |
|
|
2021
Q1 | – | Sell |
-36,855
| Closed | -$1.02M | – | 9688 |
|
|
2020
Q4 | $1.04M | Buy |
36,855
+12,823
| +53% | +$332K | ﹤0.01% | 4587 |
|
|
2020
Q3 | $605K | Buy |
+24,032
| New | +$630K | ﹤0.01% | 4860 |
|
|
2019
Q2 | – | Sell |
-20,029
| Closed | -$316K | – | 5888 |
|
|
2019
Q1 | $316K | Buy |
20,029
+6,441
| +47% | +$112K | ﹤0.01% | 4198 |
|
|
2018
Q4 | $274K | Buy |
+13,588
| New | +$299K | ﹤0.01% | 4173 |
|
|
2018
Q1 | – | Sell |
-19,172
| Closed | -$685K | – | 5534 |
|
|
2017
Q4 | $685K | Buy |
+19,172
| New | +$551K | ﹤0.01% | 2803 |
|
Other funds holding RVNC
Jane Street's RVNC Position: Q1 2025 in Review
Jane Street sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 113,150 shares — an estimated $344K sold.
Jane Street first reported a position in RVNC in Q4 2017 and held it in 19 quarters. The position peaked at $8.85M in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Jane Street reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Jane Street sold 113,150 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $344K.
- Jane Street first reported a position in Revance Therapeutics, Inc. in Q4 2017 and held it in 19 quarters.
- Jane Street's Revance Therapeutics, Inc. position peaked at $8.85M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.